Lunger John's Form 4 filing
Adaptimmune Therapeutics PLC (ADAPY) · filed Jan 12, 2024
- Accession no.
- 0001104659-24-003744
- Filed
- Jan 12, 2024
- Trade date
- Jan 11-12, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $7.80K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lunger JohnCIK 0001784487 | Officer (Chief Patient Supply Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 11, 2024 | American Depositary Shares representing Ordinary Shares | SSaleDisposed | −4,009 | $0.84 | −$3,367.56 | 6,104 | Direct | |
| Jan 12, 2024 | American Depositary Shares representing Ordinary Shares | SSaleDisposed | −5,220 | $0.85 | −$4,437 | 7,874 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.